MoneyWorks4Me

Net sales declined -26.81%  to  Rs. 221.60 million from Rs. 302.77 millions.The Net Loss for the quarter ended September 2024 is Rs. -49.95 millions as compared to Net Loss of Rs. -195.60 millions of corresponding quarter ended September 2023 Operating profit Margin for the quarter ended September 2024 improved to -7.60% as compared to -32.51% of corresponding quarter ended September 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 221.60 302.77 -26.81 221.60 632.76 -64.98 1367.97 1768.25 -22.64
Other Income 0.27 21.58 -98.75 0.27 21.66 -98.75 95.72 2.39 3905.02
PBIDT -7.60 -32.51 -76.62 -7.60 -35.35 -78.50 -182.39 -1879.36 -90.30
Interest 3.73 118.24 -96.85 3.73 224.38 -98.34 19.04 352.80 -94.60
PBDT -11.33 -150.75 -92.48 -11.33 -259.73 -95.64 -259.72 -2232.16 -88.36
Depreciation 38.62 44.85 -13.89 38.62 89.70 -56.95 184.10 1069.10 -82.78
PBT -49.95 -195.60 -74.46 -49.95 -349.43 -85.71 -443.82 -3301.26 -86.56
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -21.17 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -21.17 0.00
PAT -49.95 -195.60 -74.46 -49.95 -349.43 -85.71 -443.82 -3280.09 -86.47
Equity 165.83 165.83 0.00 165.83 165.83 0.00 165.83 165.83 0.00
PBIDTM(%) -3.43 -10.74 -68.06 -3.43 -5.59 -38.61 -13.33 -106.28 -87.46
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..